Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ligand Pharm (NQ: LGND )

156.86 USD UNCHANGED
Streaming Delayed Price Updated: 7:59 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Ligand Pharm

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Hot Stocks: Memorial Production Partners LP(NASDAQ:MEMP), Cardinal Health, Inc.(NYSE:CAH), Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI)
Lakeway, TX -- (SBWIRE) -- 03/20/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... 
From SBWire - Latest Press Releases
Stocks to Watch: LinkedIn Corp (NYSE:LNKD), Spectrum Pharmaceuticals, Teradyne, Inc.(NYSE:TER),
Lakeway, NY -- (SBWIRE) -- 03/19/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... 
From SBWire - Latest Press Releases
Traders Recap: Spectrum Pharmaceuticals, Applied Materials, Yahoo, Ciena Corporation
Lakeway, TX -- (SBWIRE) -- 03/15/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... 
From SBWire - Latest Press Releases
Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled® Melphalan
From Business Wire News Releases
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled® Melphalan
From Business Wire News Releases
Generic Drugs Stocks Review (Ligand Pharmaceuticals Inc, Hi-Tech Pharmacal Co, Actavis Inc, Momenta Pharmaceuticals)
Las Vegas, NV -- (SBWIRE) -- 02/27/2013 -- Cogonews.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news... 
From SBWire - Latest Press Releases
Ligand Receives $1.4 Million Milestone Payment from Retrophin, Inc.
From Business Wire News Releases
Notable Movers: Ligand Pharmaceuticals Inc., Telik, Inc., Hanger Inc., Hemispherx BioPharma, Inc
Lakeway, NY -- (SBWIRE) -- 02/15/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... 
From SBWire - Latest Press Releases
Ligand Reports Fourth Quarter and Full Year 2012 Financial Results
From Business Wire News Releases
Ligand to Report Fourth Quarter Results on February 13th
From Business Wire News Releases
Ligand Receives Equity Milestone Payment from Retrophin
From Business Wire News Releases
U.S. Food and Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention of Osteop
From Business Wire News Releases
U.S. Food And Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention Of Osteop
From Business Wire News Releases
Ligand Initiates Pivotal Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan in Patients with Multiple Myeloma
From Business Wire News Releases
Ligand to Present Growth Prospects, Review Key Portfolio Assets and Introduce Financial Guidance at Analyst Day Event
From Business Wire News Releases
Reminder: Ligand to Host Analyst Day on December 4th in New York City
From Business Wire News Releases
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012
Five Star Equities Provides Stock Research on Ligand Pharmaceuticals and Threshold Pharmaceuticals 
From Marketwired News Releases
Stocks Rise on Unusual Volume ( OCLR, LGND, RMBS, GMCR )
Los Angelas, CA -- (SBWIRE) -- 11/20/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... 
From SBWire - Latest Press Releases
Free Research Reports on LRN, LGND, LOW and STSI Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT 
From Marketwired News Releases
Ligand Partner GlaxoSmithKline Receives FDA Approval for New Indication for PROMACTA® (eltrombopag)
From Business Wire News Releases
Ligand Announces Positive Preclinical Data on HepDirect™ Liver-Targeted Antiviral for the Treatment of Hepatitis C
From Business Wire News Releases
Ligand Pharmaceuticals Reports Preliminary Third Quarter 2012 Results
From Business Wire News Releases
Ligand Pharmaceuticals to Restate Previous Financial Statements
From Business Wire News Releases
Ligand to Host Analyst Day on December 4th in New York City
From Business Wire News Releases
Ligand to Report Third Quarter Results on November 5th
From Business Wire News Releases
Ligand to Receive $2 Million Milestone Payment from Merck Triggered by Initiation of Phase 2b/3 Trial of Dinaciclib
From Business Wire News Releases
Ligand Pharmaceuticals Announces Second Quarter Results
From Business Wire News Releases
Ligand to Report Second Quarter Results on August 8th
From Business Wire News Releases
Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta® for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection
From Business Wire News Releases
Ligand Licensee Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis™ (carfilzomib) for Injection
From Business Wire News Releases
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.